Literature DB >> 33580870

Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer.

Saeideh Gholamzadeh Khoei1, Massoud Saidijam1, Razieh Amini1, Akram Jalali1, Rezvan Najafi2.   

Abstract

BACKGROUND: Deregulated PIN1 is associated with cancer development and progression. Herein, for the first time, we evaluate the roles that PIN1 in tumorigenic characteristics of colorectal cancer (CRC) cells.
METHODS: In this study, PIN1 expression was knocked down in SW-48 cells by synthetic small interfering RNA (siRNA). After confirming the knockdown of PIN1, cell viability, colony formation, apoptosis, autophagy, cancer stem cell (CSC)-related genes, CSC-related signaling pathways, cell migration, and 5-FU chemosensitivity were evaluated in vitro.
RESULTS: Transfection of PIN1 siRNA into SW-48 cells inhibited cancer cell proliferation, migration, and increased apoptosis and autophagy. Transfected SW-48 cells had lower properties of CSCs through the inhibition of β-catenin and Notch1 gene expression. Moreover, inhibition of PIN1 enhanced the inhibitory effect of 5-FU on SW-48 cell proliferation.
CONCLUSION: Our results indicated that targeting of PIN1 serves as a promising therapeutic solution for the suppression of tumor progression processes in CRC.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; Autophagy; CSCs; Chemosensitivity; Colorectal cancer; PIN1

Mesh:

Substances:

Year:  2021        PMID: 33580870     DOI: 10.1007/s12029-021-00600-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  46 in total

1.  Controversies in cancer stem cells: targeting embryonic signaling pathways.

Authors:  Naoko Takebe; S Percy Ivy
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  Direct reprogramming of stem cell properties in colon cancer cells by CD44.

Authors:  Ying-Jhen Su; Hsin-Mei Lai; Yi-Wen Chang; Guan-Ying Chen; Jia-Lin Lee
Journal:  EMBO J       Date:  2011-06-24       Impact factor: 11.598

3.  CD133-positive tumor cell content is a predictor of early recurrence in colorectal cancer.

Authors:  Sung Hee Lim; Jiryeon Jang; Joon Oh Park; Kyoung-Mee Kim; Seung Tae Kim; Young Suk Park; Jeeyun Lee; Hee Cheol Kim
Journal:  J Gastrointest Oncol       Date:  2014-12

4.  Identification and expansion of human colon-cancer-initiating cells.

Authors:  Lucia Ricci-Vitiani; Dario G Lombardi; Emanuela Pilozzi; Mauro Biffoni; Matilde Todaro; Cesare Peschle; Ruggero De Maria
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

5.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

Review 6.  Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.

Authors:  Delphine Tamara Marie-Egyptienne; Ines Lohse; Richard Peter Hill
Journal:  Cancer Lett       Date:  2012-11-28       Impact factor: 8.679

7.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

Review 8.  Pin1: a molecular orchestrator in the heart.

Authors:  Nirmala Hariharan; Mark A Sussman
Journal:  Trends Cardiovasc Med       Date:  2014-06-04       Impact factor: 6.677

Review 9.  Oncogenic Hijacking of the PIN1 Signaling Network.

Authors:  Alessandro Zannini; Alessandra Rustighi; Elena Campaner; Giannino Del Sal
Journal:  Front Oncol       Date:  2019-02-25       Impact factor: 6.244

10.  Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018.

Authors:  Ying Yuan; Xicheng Wang; Gong Chen; Yi Wang; Weiqi Sheng; Xinxiang Li; Aiping Zhou; Zhen Zhang; Guichao Li; Sanjun Cai; Ruihua Xu; Jin Li; Suzhan Zhang
Journal:  Chin J Cancer Res       Date:  2019-06       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.